Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activity of cefbuperazone against Bacteroides spp.

Literature DB >> 4026272

In vitro activity of cefbuperazone against Bacteroides spp.

M B Dias, N V Jacobus, S L Gorbach, F P Tally.

Abstract

The activity of cefbuperazone was tested in vitro against 287 clinical isolates of Bacteroides spp. Cefbuperazone showed good activity against B. fragilis, B. vulgatus, and other Bacteroides species, comparable to that of cefoxitin. It was relatively ineffective against B. distasonis and the B. thetaiotaomicron-ovatus group and was not active against cefoxitin-resistant Bacteroides spp.

Entities: Chemical Species

Mesh：

Substances：

Year: 1985 PMID： 4026272 PMCID： PMC180199 DOI： 10.1128/AAC.27.6.968

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

12 in total

1. Susceptibility of anaerobes to cefoxitin and other cephalosporins.

Authors: F P Tally; N V Jacobus; J G Bartlett; S L Gorbach
Journal: Antimicrob Agents Chemother Date: 1975-02 Impact factor: 5.191

2. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.

Authors: M Tai; Y Fukuoka; A Yotsuji; K Kumano; M Takahata; H Mikami; T Yasuda; I Saikawa; S Mitsuhashi
Journal: Antimicrob Agents Chemother Date: 1982-11 Impact factor: 5.191

3. Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin.

Authors: H C Neu; K P Fu; N Aswapokee; P Aswapokee; K Kung
Journal: Antimicrob Agents Chemother Date: 1979-08 Impact factor: 5.191

4. Susceptibility of the Bacteroides fragilis group in the United States in 1981.

Authors: F P Tally; G J Cuchural; N V Jacobus; S L Gorbach; K E Aldridge; T J Cleary; S M Finegold; G B Hill; P B Iannini; R V McCloskey; J P O'Keefe; C L Pierson
Journal: Antimicrob Agents Chemother Date: 1983-04 Impact factor: 5.191

5. Cefoxitin inactivation by Bacteroides fragilis.

Authors: G J Cuchural; F P Tally; N V Jacobus; P K Marsh; J W Mayhew
Journal: Antimicrob Agents Chemother Date: 1983-12 Impact factor: 5.191

6. Properties of novel beta-lactamase produced by Bacteroides fragilis.

Authors: A Yotsuji; S Minami; M Inoue; S Mitsuhashi
Journal: Antimicrob Agents Chemother Date: 1983-12 Impact factor: 5.191

7. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.

Authors: M V Borobio; J Aznar; R Jimenez; F Garcia; E J Perea
Journal: Antimicrob Agents Chemother Date: 1980-02 Impact factor: 5.191

In vitro activity of cefbuperazone against Bacteroides spp.

1. Susceptibility of anaerobes to cefoxitin and other cephalosporins.

2. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.

3. Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin.

4. Susceptibility of the Bacteroides fragilis group in the United States in 1981.

5. Cefoxitin inactivation by Bacteroides fragilis.

6. Properties of novel beta-lactamase produced by Bacteroides fragilis.

7. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.

8. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.

9. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

10. Differentiation of Bacteroides ovatus and Bacteroides thetaiotaomicron by means of bacteriophage.

1. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.

2. Activity of cefmetazole against anaerobic bacteria.